TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients

Pernille Bræmer Hertel, Dongsheng Tu, Bent Laursen Ejlertsen, Maj-Britt Raaby Jensen, Eva Balslev, Shan Jiang, Frances P. O'Malley, Kathleen I. Pritchard, Lois E. Shepherd, Annette Bartels, Nils Brunner, Torsten O. Nielsen

11 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology